Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD10 | O75832 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CYP24A1 | Q07973 | 2/20 | 0.44 |
| ▸ | VDR | P11473 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18926562 | 0.94 | CNR2 (0.44) | PSMD10ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL7324405 | 0.90 | MGLL (0.44) | PSMD10CYP24A1VDRMEN1KMT2A | |
| SCHEMBL11272133 | 0.90 | TP53 (0.49) | PSMD10ALDH1A1CYP24A1VDRMEN1 | |
| SCHEMBL7655861 | 0.90 | ALDH1A1 (0.46) | PSMD10ALDH1A1CYP24A1VDRMEN1 | |
| SCHEMBL7028389 | 0.86 | CNR2 (0.50) | PSMD10ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23727436 | 0.86 | LMNA (0.45) | PSMD10ALDH1A1CYP3A4CYP24A1VDR | |
| SCHEMBL30125726 | 0.86 | LMNA (0.45) | PSMD10ALDH1A1CYP3A4CYP24A1VDR | |
| SCHEMBL483847 | 0.84 | ALDH1A1 (0.50) | PSMD10ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL890725 | 0.84 | ALDH1A1 (0.50) | PSMD10ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL18934371 | 0.83 | ALDH1A1 (0.47) | PSMD10ALDH1A1CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111491891-B | EMM-31 material, method and use thereof | 埃克森美孚科技工程公司 | 2023-07-04 | — | — | CN | disclosed |
| EP-3728119-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | ExxonMobil Research and Engineering Company (US) | 2020-10-28 | — | — | EP | disclosed |
| US-10710889-B2 | EMM-31 materials and processes and uses thereof | EXXONMOBIL RESEARCH & ENGINEERING COMPANY (US) | 2020-07-14 | — | — | US | disclosed |
| US-20190194028-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | EXXONMOBIL RES & ENG CO (US) | 2019-06-27 | — | — | US | disclosed |
| WO-2017095705-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194028-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | CD14, MASP2, FGB | PSMD10 4303/4885ALDH1A1 4767/4885CYP3A4 2438/4885 |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | PSMD10 3980/4885ALDH1A1 4842/4885CYP3A4 1063/4885 |
| US-10710889-B2 | EMM-31 materials and processes and uses thereof | CD14, MASP2, FGB | PSMD10 4303/4885ALDH1A1 4767/4885CYP3A4 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.